🚨 WE ARE HIRING 🚨 Our team is working with top organizations in life sciences to place exceptional talent in strategic, high-growth roles. scientificsearch.com/job-see… #SciSearch #Recruiting #Hiring #Pharma #Biotech #MedDevice #Engineering #Manufacturing #LifeSciences #CPG #Food

💡 Tech transfer pros, tune into our #podcast, MedTech for Beginners for insights on bringing tech to healthcare markets. 🚀 🔗 pymsconsultancy.co.uk/medtec… #TechnologyTransfer #MedTechPodcast #MedicalInnovation #HealthTech #DigitalHealth #HealthCareInnovation #MedDevice

Hot jobs. Smart teams. Big impact. 🔥 See what’s open now. scientificsearch.com/open-jo… #SciSearch #lifesciences #pharma #biotech #meddevice

THUNDERBOLT has received CE Mark, expanding Penumbra’s computer assisted vacuum thrombectomy technology for neuro intervention in Europe. Read more here: peninc.info/49ZMuGu. #CAVT #NeuroIntervention #Innovation #MedDevice #MedTech

Penumbra's THUNDERBOLT receives FDA clearance - bringing computer assisted vacuum thrombectomy technology to neuro intervention. Read more here: bit.ly/4uqFXMl. #NeuroIntervention #CAVT #MedDevice #MedTech

Penumbra has been named one of @BusinessInsider's America's High Growth Companies of 2026. Driven by innovation and advanced technologies, we continue to expand our impact in healthcare and patient outcomes. Read more here: peninc.info/43lPDwG #MedTech #MedDevice #Innovation

Your next opportunity could change lives. 🧬🧪⚕️ Explore open roles with leading organizations across the life sciences! scientificsearch.com/open-jo… #SciSearch #Hiring #LifeSciences #Pharma #Biotech #MedDevice #Food #Beverage #CPG #Manufacturing

We are excited to launch our annual Global Sales Meeting (GSM) this Thursday. This event will bring together leadership, sales, clinical, and marketing teams from all regions to collaborate, reflect on last year’s performance, and develop strategies for the upcoming year aimed at strengthening physician partnerships and improving patient care. The theme “All Systems Go” is the signal that preparation has met opportunity. Just like a successful space launch, every system matters — our people, our strategy, our innovation, and our execution. When we are aligned and mission-ready, there’s no limit to how far we can go. Stay tuned to our social profiles to hear more from GSM! #Angiodynamics #patientcare #meddevice

🤖 #MedTech companies, get some different perspectives. Our podcast brings you industry insights and strategies. 🎧 pymsconsultancy.co.uk/medtec… #HealthTechGrowth #MedicalInnovation #Medtech #MedicalDevices #HealthTech #DigitalHealth #HealthCareInnovation #MedDevice #NHSMarketAccess

Reflecting on a memorable few days at the 45ª Jornada Paulista de Cirurgia Plástica in São Paulo. A heartfelt thank you to Next Stage for the work they're doing to bring SYLKE® to the Brazilian market. 🇧🇷 It was a pleasure connecting with so many plastic surgeons and getting to share the value SYLKE® can bring to their skin closure practice. Até a próxima, São Paulo. #SYLKEInternational #SkinClosure #MedDevice #PlasticSurgery

Ever wondered what goes into ensuring the durability of Sonosite transducers? Take a behind-the-scenes look at our testing process and discover how they're built to last: brnw.ch/21x3cTU #UltrasoundTransducer #MedicalDevice #MedDevice #PointOfCareUltrasound

We’re live NOW @AmerUrological #AUAInnovationNexus #AUA2026-!- the house is packed w startups, venture capital, urologists, manufacturers.. ENERGY is palpable to IGNITE DISCOVERY. 🔥 @MaleHealthDoc #MedDevice #Urology #innovators #HealthTech #AI #diagnostics @SocietyofBPD @Endo_Society

Read the latest STORM-PE RCT 90-day data, presented at #SIR26TOR: peninc.info/4cgMYtz #MedTech #MedDevice #CAVT #STORMPE #RCT @SIRspecialists

Read the latest STORM-PE RCT 90-day data, presented at #SIR26TOR: peninc.info/4cgMYtz #MedTech #MedDevice #CAVT #STORMPE #RCT @SIRspecialists

Thank you to the team at @SanfordHealth for a great day of demos and discussion. Conversations like these are a reminder of how impactful collaboration can be when institutions place innovation at the center of their approach to patient care. #AugmentedReality #MedTech #MedDevice

Medical device supply chains are evolving FAST! From AI-driven inventory to blockchain for traceability, we're tackling shortages & ensuring timely delivery. What's your biggest supply hurdle? #MedTech #HealthcareSupplyChain #MedDevice

Learn about new data showing CAVT's role in treating PE patients. Hear from Dr. Hoots as he breaks down what this means for patient care and healthcare resource utilization. #CAVT #MarketAccess #MedTech #MedDevice

We're hiring! 📍 Dallas, TX Customer Service/Sales Support Representative — be part of the operational backbone of our sales team, getting life-saving vascular tech to physicians when it matters most. Behind every order is a patient. vesalio.com/about/careers/cu… #MedDevice #NowHiring

🎉 Ruby XL earns both the Innovation Award (Vascular Solutions) and Product Launches Award (Endovascular Devices) at the 2025 Medical Device Network Excellence Awards. Read more here: peninc.info/4atZepk #RubyXL #MedDevice #Innovation

𝐓𝐡𝐞 𝐓𝐫𝐮𝐦𝐩 𝐚𝐝𝐦𝐢𝐧𝐢𝐬𝐭𝐫𝐚𝐭𝐢𝐨𝐧 𝐣𝐮𝐬𝐭 𝐬𝐢𝐠𝐧𝐚𝐥𝐞𝐝 𝐫𝐞𝐭𝐫𝐞𝐚𝐭 𝐨𝐧 𝟑𝟒𝟎𝐁 𝐫𝐞𝐟𝐨𝐫𝐦. Site-neutral payments went live January 1. Price transparency enforcement got delayed again. And 1/3 of hospital M&A deals last year involved a distressed seller. The system isn’t broken. It’s working exactly as designed, just not for patients, physicians, or clinicians. 340B Rebate Pilot Retreat: DOJ discussing returning HRSA’s pilot approvals for reconsideration. Upfront discounts stay. Academic and large non profit health systems win. FTC Blocks Edwards/JenaValve: $945M TAVR-AR deal halted. Edwards terminated. Site-Neutral Now Live: 40% OPPS rate hits off-campus HOPDs. Estimated $290M spending reduction. Price Transparency Delayed to April: Requirements effective Jan. 1. Enforcement postponed. Again. Do you see the pattern? Record Distressed M&A: 33% of 2024 deals involved distressed party. Consolidation accelerating. The largest health systems aren’t absorbing struggling hospitals out of charity. They’re buying market share at a discount. (Subsidized bonds are nice….) And the regulatory apparatus keeps giving them runway. This is what happens when MedDevice, Pharma, Health Systems, and Insurance pays, sorry donates to, lawmakers $950M per annum vs patients ($0.00) and physicians ($7.0M). There are other ways to win and they require coopetition. Can we pull it off? The Rojas Report drops at 10:30am.